News
WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback